The Tecan Group announced that Dr. Klaus Lun, Head of Corporate Development and a member of the Management Board of the company since June 2013, has been appointed Head of the Life Sciences Business division. On December 14, 2016, The company announced that Dr. Stefan Traeger, Head of the Life Sciences Business division and member of the Management Board since July 2013, will be leaving the company to become Chief Executive Officer of another publicly listed company. Klaus Lun will take over his new role from Stefan Traeger effective February 1, 2017. He will continue in his role as Head of Corporate Development in addition to the new position until a successor for this role has been found. Before joining the company, Klaus Lun was Vice President Global Product Marketing at Molecular Devices Inc., with responsibility for strategy development, positioning and marketing for the entire product portfolio.